{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,5,4]],"date-time":"2025-05-04T05:40:04Z","timestamp":1746337204600,"version":"3.40.4"},"reference-count":38,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"39","license":[{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100002322","name":"Coordena\u00e7\u00e3o de Aperfei\u00e7oamento de Pessoal de N\u00edvel Superior","doi-asserted-by":"crossref","award":["001"],"award-info":[{"award-number":["001"]}],"id":[{"id":"10.13039\/501100002322","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"abstract":"<jats:sec>\n            <jats:title>Abstract<\/jats:title>\n            <jats:p>The presynaptic dopamine transporter (DAT) modulates the uptake of dopamine by regulating its concentration in the central nervous system. We aimed to evaluate the DAT binding potential (DAT-BP) in a sample of healthy Brazilians through technetium-99 metastable TRODAT-1 single-photon emission computed tomography imaging.<\/jats:p>\n            <jats:p>We selected 126 healthy individuals comprising 72 men and 54 women, aged 18 to 80\u200ayears. We conducted semi-quantitative evaluation in transaxial slices, following which we identified the regions of interest in the striatal region using the occipital lobe as a region of non-specific DAT-BP.<\/jats:p>\n            <jats:p>We found a decrease in DAT-BP in healthy individuals aged over 30\u200ayears, culminating in a 42% mean reduction after 80\u200ayears. There was no difference in the decrease by age group between the right (linear regression test [<jats:italic toggle=\"yes\">R<\/jats:italic>\n                                 <jats:sup>2<\/jats:sup>] linear\u200a=\u200a0.466) and left striatum (<jats:italic toggle=\"yes\">R<\/jats:italic>\n                                 <jats:sup>2<\/jats:sup> linear\u200a=\u200a0.510). Women presented a higher DAT-BP than men (women: <jats:italic toggle=\"yes\">R<\/jats:italic>\n                                 <jats:sup>2<\/jats:sup> linear\u200a=\u200a0.431; men: <jats:italic toggle=\"yes\">R<\/jats:italic>\n                                 <jats:sup>2<\/jats:sup> linear\u200a=\u200a0.457); nonetheless, their decrease by age group was equal to that in men.<\/jats:p>\n            <jats:p>Our study sheds light on important DAT-BP findings in healthy Brazilian subjects. Our results will facilitate understanding of brain illnesses that involve the dopamine system, such as neuropsychiatric disorders.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1097\/md.0000000000027192","type":"journal-article","created":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T19:20:13Z","timestamp":1633116013000},"page":"e27192","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":0,"title":["Evaluation of dopamine transporter density in healthy Brazilians using Tc-99m TRODAT-1 SPECT"],"prefix":"10.1097","volume":"100","author":[{"given":"Marilia Alves dos","family":"Reis","sequence":"first","affiliation":[{"name":"Laboratory of Integrative Neuroscience, Universidade Federal de S\u00e3o Paulo (LiNC- EPM\/UNIFESP), S\u00e3o Paulo, Brazil"},{"name":"Department of Psychiatry, Universidade Federal de S\u00e3o Paulo, S\u00e3o Paulo, Brazil"},{"name":"Department of Diagnostic Imaging, Universidade Federal de S\u00e3o Paulo (DDI\/UNIFESP), S\u00e3o Paulo, Brazil"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0993-8017","authenticated-orcid":false,"given":"Ary","family":"Gadelha","sequence":"additional","affiliation":[{"name":"Laboratory of Integrative Neuroscience, Universidade Federal de S\u00e3o Paulo (LiNC- EPM\/UNIFESP), S\u00e3o Paulo, Brazil"},{"name":"Department of Psychiatry, Universidade Federal de S\u00e3o Paulo, S\u00e3o Paulo, Brazil"},{"name":"Schizophrenia Program of the Department of Psychiatry, Universidade Federal de S\u00e3o Paulo (PROESQ \u2013 EPM\/UNIFESP), S\u00e3o Paulo, Brazil"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andr\u00e9 C.","family":"Fel\u00edcio","sequence":"additional","affiliation":[{"name":"Hospital Israelita Albert Einstein, S\u00e3o Paulo, Brazil"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marcelo Queiroz","family":"Hoexter","sequence":"additional","affiliation":[{"name":"Department of Psychiatry, Universidade Federal de S\u00e3o Paulo, S\u00e3o Paulo, Brazil"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4206-5289","authenticated-orcid":false,"given":"Ilza Rosa","family":"Batista","sequence":"additional","affiliation":[{"name":"Department of Diagnostic Imaging, Universidade Federal de S\u00e3o Paulo (DDI\/UNIFESP), S\u00e3o Paulo, Brazil"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9186-9243","authenticated-orcid":false,"given":"Pedro","family":"Braga-Neto","sequence":"additional","affiliation":[{"name":"Neurology Division, Department of Clinical Medicine, Universidade Federal do Cear\u00e1, Cear\u00e1, Brazil"},{"name":"Center of Health Sciences, Universidade Estadual do Cear\u00e1, Cear\u00e1, Brazil"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mariana","family":"Calzavara","sequence":"additional","affiliation":[{"name":"Department of Psychiatry, Universidade Federal de S\u00e3o Paulo, S\u00e3o Paulo, Brazil"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daniel Alves","family":"Cavagnolli","sequence":"additional","affiliation":[{"name":"Department of Psychobiology, Universidade Federal de S\u00e3o Paulo, S\u00e3o Paulo, Brazil."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cinthia","family":"Higuchi","sequence":"additional","affiliation":[{"name":"Laboratory of Integrative Neuroscience, Universidade Federal de S\u00e3o Paulo (LiNC- EPM\/UNIFESP), S\u00e3o Paulo, Brazil"},{"name":"Department of Psychiatry, Universidade Federal de S\u00e3o Paulo, S\u00e3o Paulo, Brazil"},{"name":"Schizophrenia Program of the Department of Psychiatry, Universidade Federal de S\u00e3o Paulo (PROESQ \u2013 EPM\/UNIFESP), S\u00e3o Paulo, Brazil"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Melissa Furlaneto Lellis","family":"Leite","sequence":"additional","affiliation":[{"name":"Department of Diagnostic Imaging, Universidade Federal de S\u00e3o Paulo (DDI\/UNIFESP), S\u00e3o Paulo, Brazil"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Solange Amorim","family":"Nogueira","sequence":"additional","affiliation":[{"name":"Hospital Israelita Albert Einstein, S\u00e3o Paulo, Brazil"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jairo","family":"Wagner","sequence":"additional","affiliation":[{"name":"Hospital Israelita Albert Einstein, S\u00e3o Paulo, Brazil"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mario Luiz Vieira","family":"Castiglioni","sequence":"additional","affiliation":[{"name":"Department of Diagnostic Imaging, Universidade Federal de S\u00e3o Paulo (DDI\/UNIFESP), S\u00e3o Paulo, Brazil"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ming Chi","family":"Shih","sequence":"additional","affiliation":[{"name":"Department of Psychiatry, Universidade Federal de S\u00e3o Paulo, S\u00e3o Paulo, Brazil"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0868-4449","authenticated-orcid":false,"given":"Rodrigo Affonseca","family":"Bressan","sequence":"additional","affiliation":[{"name":"Laboratory of Integrative Neuroscience, Universidade Federal de S\u00e3o Paulo (LiNC- EPM\/UNIFESP), S\u00e3o Paulo, Brazil"},{"name":"Department of Psychiatry, Universidade Federal de S\u00e3o Paulo, S\u00e3o Paulo, Brazil"},{"name":"Schizophrenia Program of the Department of Psychiatry, Universidade Federal de S\u00e3o Paulo (PROESQ \u2013 EPM\/UNIFESP), S\u00e3o Paulo, Brazil"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","published-online":{"date-parts":[[2021,10,1]]},"reference":[{"key":"R1-20250504","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1007\/s002590050191","article-title":"Pharmacological effects of dopaminergic drugs on in vivo binding of [99mTc]TRODAT-1 to the central dopamine transporters in rats","volume":"25","author":"Dresel","year":"1998","journal-title":"Eur J Nucl Med"},{"key":"R2-20250504","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1021\/jm970742b","article-title":"Specificity of diastereomers of [99mTc]TRODAT-1 as dopamine transporter imaging agents","volume":"41","author":"Meegalla","year":"1998","journal-title":"J Med Chem"},{"key":"R3-20250504","first-page":"660","article-title":"Simultaneous SPECT studies of pre- and postsynaptic dopamine binding sites in baboons","volume":"40","author":"Dresel","year":"1999","journal-title":"J Nucl Med"},{"key":"R4-20250504","doi-asserted-by":"crossref","first-page":"1321","DOI":"10.1016\/0140-6736(91)92989-F","article-title":"Parkinson's disease: pathophysiology","volume":"337","author":"Agid","year":"1991","journal-title":"Lancet"},{"key":"R5-20250504","first-page":"S6","article-title":"PET studies on the early and differential diagnosis of Parkinson's disease","volume":"43","author":"Brooks","year":"1993","journal-title":"Neurology"},{"key":"R6-20250504","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1590\/S1516-31802006000300014","article-title":"Parkinson's disease and dopamine transporter neuroimaging - a critical review","volume":"124","author":"Shih","year":"2006","journal-title":"Sao Paulo Med J"},{"key":"R7-20250504","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/S0969-8051(99)00090-6","article-title":"The preclinical pharmacologic study of dopamine transporter imaging agent [99mTc]TRODAT-1","volume":"27","author":"Fang","year":"2000","journal-title":"Nucl Med Biol"},{"key":"R8-20250504","doi-asserted-by":"crossref","first-page":"09","DOI":"10.1021\/jm960532j","article-title":"Synthesis and characterization of Technetium-99m-labeled tropanes as dopamine transporter-imaging agents","volume":"40","author":"Meegalla","year":"1997","journal-title":"J Med Chem"},{"key":"R9-20250504","doi-asserted-by":"crossref","first-page":"02","DOI":"10.1053\/snuc.2003.127296","article-title":"Radiopharmaceuticals for single-photon emission computed tomography brain imaging","volume":"33","author":"Kung","year":"2003","journal-title":"Semin Nucl Med"},{"key":"R10-20250504","first-page":"372","article-title":"[99mTc]TRODAT-1: a novel technetium-99m complex as a dopamine transporter imaging agent","volume":"24","author":"Kung","year":"1997","journal-title":"Eur J Nucl Med"},{"key":"R11-20250504","first-page":"150","article-title":"Kinetic modeling of [99mTc]TRODAT-1: a dopamine transporter imaging agent","volume":"40","author":"Kushner","year":"1999","journal-title":"J Nucl Med"},{"key":"R12-20250504","doi-asserted-by":"crossref","first-page":"628","DOI":"10.1590\/S0004-282X2006000400021","article-title":"Neuroimaging of the dopamine transporter in Parkinson's disease - first study using [99mTc]-TRODAT-1 and SPECT in Brazil","volume":"64","author":"Shih","year":"2006","journal-title":"Arq Neuropsiquiatr"},{"key":"R13-20250504","doi-asserted-by":"crossref","first-page":"07","DOI":"10.1590\/S0004-282X2009000100003","article-title":"Clinical and molecular neuroimaging characteristics of Brazilian patients with Parkinson's disease and mutations in PARK2 or PARK8 genes","volume":"67","author":"Barsottini","year":"2009","journal-title":"Arq Neuropsiquiatr"},{"key":"R14-20250504","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1002\/mds.21315","article-title":"Higher nigroestriatal dopamine neuron loss in early than late onset Parkinson's disease? A [99mTc]-TRODAT-1 SPECT study","volume":"22","author":"Shih","year":"2007","journal-title":"Mov Disord"},{"key":"R15-20250504","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1016\/j.clineuro.2009.12.010","article-title":"Degenerative parkinsonism in patients whit psychogenic parkinsonism: a dopamine transporter imaging study","volume":"112","author":"Fel\u00edcio","year":"2010","journal-title":"Clin Neurol Neurosurg"},{"key":"R16-20250504","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1007\/s00213-010-1867-y","article-title":"Higher dopamine transporter density in Parkinson's disease patients with depression","volume":"211","author":"Fel\u00edcio","year":"2010","journal-title":"Psychopharmacology (Berl)"},{"key":"R17-20250504","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1016\/j.jns.2009.12.024","article-title":"Evaluation of patients with clinically unclear Parkinsonian Syndromes submitted to brain SPECT imaging using the technetium-99m labeled tracer TRODAT-1","volume":"291","author":"Fel\u00edcio","year":"2010","journal-title":"J Neurol Sci"},{"key":"R18-20250504","doi-asserted-by":"crossref","first-page":"1527","DOI":"10.1007\/BF01254479","article-title":"Imaging of dopamine transporters in humans with technetium99 m TRODAT-1","volume":"23","author":"Kung","year":"1996","journal-title":"Eur J Nucl Med"},{"key":"R19-20250504","first-page":"2069","article-title":"Biodistribution and dosimetry of TRODAT-1: a technetium-99 m tropane for imaging dopamine transporters","volume":"39","author":"Mozley","year":"1998","journal-title":"J Nucl Med"},{"key":"R20-20250504","doi-asserted-by":"crossref","first-page":"1714","DOI":"10.1007\/s002590000371","article-title":"Simplified quantification of dopamine transporters in humans using [99mTc]TRODAT-1 and single-photon emission tomography","volume":"27","author":"Acton","year":"2000","journal-title":"Eur J Nucl Med"},{"key":"R21-20250504","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1523\/JNEUROSCI.16-02-00436.1996","article-title":"The dopamine transporter is localized to dendritic and axonal plasma membranes of nigrostriatal dopaminergic neurons","volume":"16","author":"Nirenberg","year":"1996","journal-title":"J Neurosci"},{"key":"R22-20250504","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1016\/S0026-895X(25)08925-4","article-title":"Cloning, pharmacological characterization, and chromosome assignment of the human dopamine transporter","volume":"42","author":"Giros","year":"1992","journal-title":"Mol Pharmacol"},{"key":"R23-20250504","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1016\/0169-328X(95)00018-N","article-title":"Human and mouse dopamine transporter genes: conservation of 5\u2019-fl anking sequence elements and gene structures","volume":"30","author":"Donovan","year":"1995","journal-title":"Brain Res Mol Brain Res"},{"key":"R24-20250504","doi-asserted-by":"crossref","first-page":"1104","DOI":"10.1016\/S0888-7543(05)80138-7","article-title":"Human dopamine transporter gene (DAT1) maps to chromosome 5p15.3 and displays a VNTR","volume":"14","author":"Vandenbergh","year":"1992","journal-title":"Genomics"},{"issue":"(3 pt 1)","key":"R25-20250504","doi-asserted-by":"crossref","first-page":"1714","DOI":"10.1523\/JNEUROSCI.15-03-01714.1995","article-title":"The dopamine transporter: immunochemical characterization and localization in brain","volume":"15","author":"Ciliax","year":"1995","journal-title":"J Neurosci"},{"key":"R26-20250504","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1176\/appi.ajp.157.3.457","article-title":"Low dopamine D(2) receptor binding potential in social phobia","volume":"157","author":"Schneier","year":"2000","journal-title":"Am J Psychiatry"},{"key":"R27-20250504","first-page":"1129","article-title":"SPECT imaging of dopamine transporters in human brain with iodine-123-fl uoroalkyl analogs of beta-CIT","volume":"37","author":"Abi-Dargham","year":"1996","journal-title":"J Nucl Med"},{"key":"R28-20250504","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1002\/(SICI)1096-9861(19990621)409:1<25::AID-CNE3>3.0.CO;2-E","article-title":"Dopamine transporter-immunoreactive neurons decrease with age in the human substantia nigra","volume":"409","author":"Ma","year":"1999","journal-title":"J Comp Neurol"},{"key":"R29-20250504","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1002\/ana.410260409","article-title":"Striatal dopamine deficiency in Parkinson's disease: role of aging","volume":"26","author":"Scherman","year":"1989","journal-title":"Ann Neurol"},{"key":"R30-20250504","first-page":"1175","article-title":"Age-related decline in striatal dopamine transporter binding with iodine-123-beta-CITSPECT","volume":"36","author":"Van Dyck","year":"1995","journal-title":"J Nucl Med"},{"key":"R31-20250504","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1007\/s12149-017-1168-1","article-title":"Age-related effects and gender differences in Japanese healthy controls for [123I] FP-CIT SPECT","volume":"31","author":"Yamamoto","year":"2017","journal-title":"Ann Nucl Med"},{"key":"R32-20250504","doi-asserted-by":"crossref","first-page":"1492","DOI":"10.1176\/appi.ajp.158.9.1492","article-title":"Striatal dopamine transporters and cognitive functioning in healthy men and women","volume":"158","author":"Mozley","year":"2001","journal-title":"Am J Psychiatry"},{"key":"R33-20250504","doi-asserted-by":"crossref","first-page":"10531","DOI":"10.1038\/s41598-019-47026-6","article-title":"Beneficial effect of estrogen on nigrostriatal dopaminergic neurons in drug-naive postmenopausal Parkinson's disease","volume":"9","author":"Lee","year":"2019","journal-title":"Sci Rep"},{"key":"R34-20250504","doi-asserted-by":"crossref","first-page":"872","DOI":"10.3390\/cells8080872","article-title":"Molecular imaging of the dopamine transporter","volume":"8","author":"Palermo","year":"2019","journal-title":"Cells"},{"key":"R35-20250504","doi-asserted-by":"crossref","first-page":"1693","DOI":"10.1093\/brain\/awh198","article-title":"Biomarkers and Parkinson's disease","volume":"127","author":"Michell","year":"2004","journal-title":"Brain"},{"key":"R36-20250504","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1590\/S1516-44462007000200003","article-title":"Can molecular imaging techniques identify biomarkers for neuropsychiatric disorders?","volume":"29","author":"Bressan","year":"2007","journal-title":"Rev Bras Psiquiatr"},{"key":"R37-20250504","doi-asserted-by":"crossref","first-page":"628","DOI":"10.1590\/S0004-282X2006000400021","article-title":"Neuroimaging of the dopamine transporter in Parkinson's disease: first study using [99mTc]TRODAT-1 and SPECT in Brazil","volume":"64","author":"Shih","year":"2006","journal-title":"Arq Neuropsiquiatr"},{"key":"R38-20250504","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1186\/s13550-018-0450-0","article-title":"Dopamine transporter imaging with [18F]FE-PE2I PET and [123I]FP-CIT SPECT\u2014a clinical comparison","volume":"8","author":"Mo","year":"2018","journal-title":"EJNMMI Res"}],"container-title":["Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000027192","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,4]],"date-time":"2025-05-04T05:12:07Z","timestamp":1746335527000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000027192"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,10,1]]},"references-count":38,"journal-issue":{"issue":"39","published-online":{"date-parts":[[2021]]}},"URL":"https:\/\/doi.org\/10.1097\/md.0000000000027192","relation":{},"ISSN":["0025-7974","1536-5964"],"issn-type":[{"type":"print","value":"0025-7974"},{"type":"electronic","value":"1536-5964"}],"subject":[],"published":{"date-parts":[[2021,10,1]]},"assertion":[{"value":"2021-04-26","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2021-08-22","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}